Holdco Nuvo Group D.G Ltd. (NUVOQ) vs Nexalin Technology, Inc. (NXL)

Holdco Nuvo Group D.G Ltd. and Nexalin Technology, Inc. are both Medical Devices companies. Nexalin Technology, Inc. is the larger, with a market value of $2.6M against $2.1M — 1.2× the size. Holdco Nuvo Group D.G Ltd. has the higher net margin (0.00% vs −4,138.5%) and the higher return on invested capital (0.00% vs −1,108.8%). Across the 12 metrics below, Holdco Nuvo Group D.G Ltd. leads on 9 and Nexalin Technology, Inc. on 3.

Valuation

Metric NUVOQ NXL Medical Devices median
P/E n/m n/m 23.22
P/S n/m 7.62 2.34
P/B n/m 1.09 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales n/m 3.02 2.24
Earnings yield 0.00% (613.38%) (10.09%)
Free cash flow yield 0.00% (383.03%) (8.47%)

Profitability

Metric NUVOQ NXL Medical Devices median
Gross margin — 86.14% 56.01%
Operating margin 0.00% (4,201.66%) (15.03%)
Net margin 0.00% (4,138.49%) (20.40%)
Free cash flow margin 0.00% (2,917.96%) (7.24%)
Return on equity 63.38% (240.25%) (15.32%)
Return on assets (930.47%) (187.89%) (19.72%)
Return on invested capital 0.00% (1,108.82%) (10.33%)

Growth

Metric NUVOQ NXL Medical Devices median
Revenue growth (TTM) — 24.26% 8.80%
EPS growth (last fiscal year) (53.51%) 39.76% 29.03%
Revenue growth, 5-year CAGR — 4.42% 15.47%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric NUVOQ NXL Medical Devices median
Debt to equity (0.17) 0.00 0.07
Current ratio 0.05 1.25 2.50
Net debt to EBITDA (0.67) 0.44 0.49

Dividend

Metric NUVOQ NXL Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric NUVOQ NXL Medical Devices median
Market cap 2.12m 2.57m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack